Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy

Schabel, 1975, Synergism and antagonism among antitumor agents, 595 Mulder, 1977, Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy, Europ. J. Cancer, 13, 1123, 10.1016/0014-2964(77)90011-1 Lelieveld, 1976, Biological activity of two derivatives and six possible metabolites of Cyclophosphamide (NSC-26271), Cancer Treatment Rep., 60, 373 Till, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat. Res., 14, 213, 10.2307/3570892 van Putten, 1972, Cell-cycle specificity and therapeutic effectiveness of cytostatic agents, Cancer Chemother. Rep., 56, 691 Valeriote, 1968, Synergistic action of cyclophosphamide and 1, 3-bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma, J. nat. Cancer Inst., 40, 935 Lin, 1972, Chemotherapy of the transplanted KHT fibrosarcoma in mice, Ser. Haematol., 5, 89 Mayo, 1972, Success and failure in the treatment of solid tumors. III. “Cure” of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95441) and surgery-chemotherapy, Cancer Chemother. Rep., 56, 183 P. J. van Kranenburg-Voogd, Personal communication (1977). Murphy, 1975, Phase I–II study of combination chemotherapy with cyclophosphamide (CTX) and methyl CCNU, 16, 253 Rossi, 1975, Methyl-CCNU (NSC-95441) versus Methyl-CCNU plus Cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer, Cancer Chemother. Rep., 59, 1161 Vietti, 1974, Schedule dependency of the synergistic lethal effects of cyclophosphamide (Cy) and 1, 3-bis(2-chloro-ethyl)-1-nitrosourea (BCNU), 15, 141 de Vita, 1972, The effect of chemotherapy on the growth of leukemia L1210. II. Persistance of a nitrosourea-induced change in the growth characteristics of transplant generations, Cell Tiss. Kinet., 5, 459 Wheeler, 1973, Recent advances in the biochemical pharmacology of selected alkylating agents, 5, 1167